CAS 1034001-51-8: [RuCl(p-cymene)((R)-tolbinap)]Cl
Description:The chemical substance with the name "[RuCl(p-cymene)((R)-tolbinap)]Cl" is a ruthenium complex that features a ruthenium center coordinated to a chloride ion, a p-cymene ligand, and a chiral ligand known as (R)-tolbinap. This compound is notable for its potential applications in asymmetric catalysis, particularly in organic synthesis, due to the presence of the chiral ligand which can induce enantioselectivity in reactions. The p-cymene ligand contributes to the stability and solubility of the complex, while the ruthenium center is known for its versatility in various catalytic processes. The compound's chirality, derived from the (R)-tolbinap ligand, allows it to interact selectively with substrates, making it valuable in the synthesis of chiral molecules. Additionally, the presence of multiple chloride ligands can influence the reactivity and coordination properties of the complex. Overall, this ruthenium complex exemplifies the intersection of coordination chemistry and catalysis, showcasing the importance of metal-ligand interactions in developing efficient catalytic systems.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | [RuCl(p-cymene)((R)-tolbinap)]Cl REF: 3B-R0148CAS: | - - - | To inquire | Tue 25 Feb 25 |
![]() | [RuCl(p-cymene)((R)-tolbinap)]Cl REF: 3D-JRB00151CAS: 1034001-51-8 | Min. 95% | - - - | Discontinued product |

[RuCl(p-cymene)((R)-tolbinap)]Cl
Ref: 3B-R0148
1g | 144.00 € | ||
200mg | 46.00 € |

[RuCl(p-cymene)((R)-tolbinap)]Cl
Ref: 3D-JRB00151
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |